3D Diagnostic Imaging Services Market Report 2025

This 3D Diagnostic Imaging Services market report provides a comprehensive analysis of the market’s characteristics, size, and growth, including segmentation, regional and country-level breakdowns, competitive landscape, market shares, trends, and strategies. It also tracks historical and forecasted market growth across various geographies.

The 3D diagnostic imaging services market size has grown strongly in recent years. It will grow from $221.41 billion in 2024 to $234 billion in 2025 at a compound annual growth rate (CAGR) of 5.7%. The growth in the historic period can be attributed to increase in need for point-of-care imaging systems, rise in incidence of chronic diseases, surge in demand for optical imaging, increase in usage of 3D imaging and rising healthcare expenditure.

The 3D diagnostic imaging services market size is expected to see strong growth in the next few years. It will grow to $303.02 billion in 2029 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to growing need for early diagnosis and preventive medicine, increasing investments in healthcare infrastructure, increasing demand for 3D accelerometers in smartphones and gaming consoles, growing demand for 3D image sensors from verticals and increasing geriatric population. Major trends in the forecast period include advancements in technology, use of artificial intelligence (AI), increasing investments, product innovation and collaborations and acquisitions.

The demand for point-of-care testing (PoCT) has been on a consistent rise, and this upward trend is expected to persist, thereby bolstering the market for 3D diagnostic imaging services. This growing demand is underpinned by the fact that PoCT enables healthcare providers to obtain real-time diagnostic results of laboratory quality within minutes, as opposed to hours. Additionally, the evolving healthcare delivery model is geared toward delivering cost-effective care to patients within their homes. Especially in developing countries, where more effective care for infectious diseases is imperative, PoCT technologies are becoming increasingly vital. These technologies offer efficient care through user-friendly devices and enhanced analytical performance. Recent strides in the speed, usability, and affordability of medical imaging, particularly with the integration of 3D capabilities, have significantly expanded the capabilities of PoCT testing systems. These advancements are serving as a powerful driver for the growth of the 3D diagnostic imaging services market.

The 3D diagnostic imaging services market is poised for growth, primarily due to the increasing prevalence of chronic diseases. Chronic diseases are persistent, long-term medical conditions that necessitate continuous management and treatment. 3D diagnostic imaging services play a pivotal role in the management of chronic diseases by offering in-depth visualization of affected organs and tissues. This capability allows for more precise monitoring of disease progression and treatment effectiveness, ultimately leading to enhanced patient care and outcomes. For example, data from the National Center for Biotechnology Information (NCBI), a branch of the US-based National Library of Medicine, suggests that by 2050, the number of individuals aged 50 years and older with at least one chronic ailment is projected to surge by 99.5%, increasing from 71.522 million in 2020 to 142.66 million. Consequently, the increasing prevalence of chronic diseases is anticipated to be a driving force behind the expansion of the 3D diagnostic imaging services market.

The implementation of enhanced data storage and information sharing systems, such as medical cloud technology, is paving the way for increased growth prospects within the 3D diagnostic imaging industry. This is attributed to the fact that medical imaging necessitates robust infrastructure for processing, storing, sharing, and utilizing vast volumes of medical data to make informed diagnostic and treatment decisions. The integration of advanced cloud computing solutions in medical imaging effectively addresses these challenges. Cloud computing technology is an evolving solution that provides answers to the complexities of delivering intricate services and facilitating data exchange over the internet. It offers a means to seamlessly share medical data across geographical regions, ensuring more patients have access to the required medical resources. This technology simplifies data retrieval and empowers medical professionals with convenient access to clinical image data that is both clear and informative. Consequently, medical cloud imaging has emerged as a critical domain within the realm of cloud computing, offering substantial benefits to the healthcare and diagnostic imaging sectors.

Prominent players in the 3D diagnostic imaging services market are actively engaged in developing cutting-edge imaging solutions and extending their global presence to secure a competitive advantage in the burgeoning healthcare sector. Notably, the introduction of the Ultrasound Compact System 5000 Series represents a significant milestone, providing the high-quality imaging necessary for confident diagnoses within a portable unit. For instance, in November 2022, Koninklijke Philips N.V., a diversified technology company headquartered in the Netherlands, launched the next-generation compact portable ultrasound solution. This innovation, Philips' Compact 5000 Series, is specifically designed to bring the diagnostic quality traditionally associated with premium cart-based ultrasound systems to a broader patient population. With a focus on portability and versatility while upholding image quality and performance, the Compact 5000 series streamlines the process of conducting accurate ultrasound exams for a wider range of patients. This initiative demonstrates the commitment of major companies to meet the evolving needs of the healthcare industry through innovative solutions and expanded accessibility.

In April 2023, Molecular Devices, a US-based company specializing in mobile cardiac catheter and angiography lab solutions, completed the acquisition of Interim Diagnostic Imaging. The financial terms of the transaction were not disclosed. This strategic acquisition significantly bolsters Molecular Devices' existing fleet and enhances its product portfolio. As a result of this merger, the combined entity is now poised to provide customers with a comprehensive array of medical imaging solutions, encompassing catheterization, cleanroom, PET or CT, MRI, and CT facilities. Interim Diagnostic Imaging, based in the United States, specializes in offering both short- and long-term rentals of mobile CT scanners, mobile MRI scanners, and mobile PET scanners.

3D diagnostic imaging services encompass the utilization of optical imaging to produce three-dimensional representations of the body's internal structures. These services are instrumental for diagnostic purposes, allowing medical professionals to investigate the body's internal condition for signs of disease.

The primary techniques employed in 3D diagnostic imaging services include ultrasound, MRI, X-ray, computed tomography, and other specialized methods. Ultrasound, for instance, relies on sound waves to generate detailed images of organs, tissues, and various body structures. These services find extensive applications in fields such as oncology, cardiology, orthopedics, and more. They are utilized by diagnostic centers, hospitals, and research facilities to support medical diagnosis and treatment.

The 3D diagnostic imaging services market research report is one of a series of new reports that provides 3D diagnostic imaging services market statistics, including 3D diagnostic imaging services industry global market size, regional shares, competitors with a 3D diagnostic imaging services market share, detailed 3D diagnostic imaging services market segments, market trends and opportunities, and any further data you may need to thrive in the 3D diagnostic imaging services industry. This 3D diagnostic imaging services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Major companies operating in the 3D diagnostic imaging services market include Laboratory Corporation of America Holdings, Quest Diagnostics Inc., Alere Inc., Bio-Reference Laboratories Inc., DaVita Healthcare Partners Inc., Genomic Health Inc., Myriad Genetics Inc., NeoGenomics Inc., Sonic Healthcare Limited, Spectra Laboratories Inc., SYNLAB International GMBH, Accurate Imaging Inc., Atlantic Medical Imaging Inc., Cobalt Health Pty Ltd, Digirad Corporation, Del Medical Systems Group Inc., Front Range Mobile Imaging Inc., Inhealth Group Ltd., RadNet Inc., Teleradiology Solutions, TridentCare LLC, Koninklijke Philips NV, Siemens Healthcare GmbH, GE Healthcare Technologies Inc., Shenzhen Mindray Bio-Medical Electronics Co Ltd., Ambra Health Inc., Arterys Inc., NDS Surgical Imaging LLC, NerveVision Inc., Olympus Corporation.

North America was the largest region in the 3D diagnostic imaging services market in 2024. Western Europe was the second largest region in the 3D diagnostic imaging services market. The regions covered in the 3d diagnostic imaging services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the 3D diagnostic imaging services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The 3D diagnostic imaging services market includes revenues earned by entities by providing PET, sonography, and mammography services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.